Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer-Reference-Cited by-同舟云学术

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

Published:2012-01-26 Issue:4 Volume:366 Page:310-320
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Bear Harry D.,Tang Gong,Rastogi Priya,Geyer Charles E.,Robidoux André,Atkins James N.,Baez-Diaz Luis,Brufsky Adam M.,Mehta Rita S.,Fehrenbacher Louis,Young James A.,Senecal Francis M.,Gaur Rakesh,Margolese Richard G.,Adams Paul T.,Gross Howard M.,Costantino Joseph P.,Swain Sandra M.,Mamounas Eleftherios P.,Wolmark Norman

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1111097

Cited by 409 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A preoperative radiogenomic model based on quantitative heterogeneity for predicting outcomes in triple-negative breast cancer patients who underwent neoadjuvant chemotherapy;Cancer Imaging;2024-07-30

2. Axillary Surgery for Chemoresidual (ypN-Positive) Nodal Disease;JAMA Oncology;2024-07-01

3. Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis;Expert Review of Anticancer Therapy;2024-05-17

4. Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion;World Journal of Gastrointestinal Oncology;2024-05-15

5. Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment;PLOS Computational Biology;2024-05-03